Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Hepatitis A
SAGE documentation
2021
2012
Clear all
Type of publications
NITAG documentation
(164)
SAGE documentation
(10)
Systematic reviews (SYSVAC)
(231)
Topics
Evidence to recommendation table
(1)
GRADE table
(5)
Position paper
(3)
SAGE background document
(1)
Regions
Countries
Diseases
COVID-19
(4)
Hepatitis A
(6)
Influenza
(12)
Pneumococcal disease
(3)
Publication date
2021
(4)
2012
(6)
2023
(2)
2022
(20)
2020
(2)
Target population
Available to download in languages
English (EN)
(10)
French (FR)
(1)
10 results found
2021
∙
SAGE
Background document on the Bharat Biotech BBV152 COVAXIN® (COVID-19) vaccine
2021
∙
SAGE
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
2021
∙
SAGE
Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
2021
∙
SAGE
WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply - 16 July 2021
2012
∙
SAGE
Hepatitis A vaccine and post-exposure prophylaxis
2012
∙
SAGE
Efficacy and safety of hepatitis A vaccines
2012
∙
SAGE
Population impact of Hepatitis A immunization programs
2012
∙
SAGE
Hepatitis A vaccines and long-term protection
2012
∙
SAGE
single vs flexible dose for hepatitis A
2012
∙
WHO
WHO position paper on hepatitis A vaccines
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register